Pfizer Inc.PFE

$25.21-0.71 (-2.74%)
NYSEHealthcare24:00 UTC

Company snapshot

Market Cap
$144B
Large-cap
-28%
2016 — today
10-Year Price
-22%
2016 — today
52-Week Range
$23.29$28.55
Current $25.21· 37%

Pfizer researches, develops, and distributes biopharmaceuticals and vaccines globally. Its portfolio spans cardiovascular and women’s health (Premarin, Eliquis), oncology (Ibrance, Xtandi), and immunology (Xeljanz, Inflectra). The firm provides sterile injectables, anti-infectives, and COVID-19 treatments like Paxlovid. Its vaccine division includes Comirnaty and the Prevnar family. Pfizer also develops rare disease therapies (Vyndaqel, BeneFIX), operates a contract manufacturing unit, and partners with BioNTech and BMS.

Valuation in context

P/E ratio
19.2
Above average
Pricier than usual over the last 10 years
P/B ratio
1.6
Near historic low
Near historic low — last 10 years
EV / EBITDA
12.4
Below average
Below the 10-year average
Dividend Yield
6.8%
Near historic high
Near historic highs — last 10 years
FCF Yield
6.6%
Around average
Around the 10-year average
Free · No credit card needed

Get alerted when PFE is cheap

Set a free alert — we'll push you when P/E, yield, or other metrics cross a historical threshold.